Trademark: CAPSIDA BIOTHERAPEUTICS 2171121
Word
CAPSIDA BIOTHERAPEUTICS
ID
2171121
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
06 January 2021
Registration Date
06 January 2021
Renewal Date
06 January 2031
Owner(s)
Service
Goods and Services:
Class 1:
Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, for development of therapeutics for use in the treatment of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders.
Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, for development of therapeutics for use in the treatment of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders.
Class 5:
Pharmaceutical preparations for use in gene therapy; pharmaceutical preparations for use in gene delivery technology; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceutical preparations for the treatment of genetic diseases and disorders; and pre-filled syringes and vials containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations that facilitate administration of other pharmaceutical preparations into the brain for enhanced treatment of disorders of the central nervous system and cancer; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders, and complications associated therewith; pre-filled syringes and vials containing pharmaceutical preparations for medical purposes.
Pharmaceutical preparations for use in gene therapy; pharmaceutical preparations for use in gene delivery technology; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceutical preparations for the treatment of genetic diseases and disorders; and pre-filled syringes and vials containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations that facilitate administration of other pharmaceutical preparations into the brain for enhanced treatment of disorders of the central nervous system and cancer; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders, and complications associated therewith; pre-filled syringes and vials containing pharmaceutical preparations for medical purposes.
Class 40:
Biomanufacturing, namely, custom manufacturing of pharmaceuticals using biological organisms in the manufacturing process; providing technical information in the field of pharmaceutical manufacturing; custom manufacture of pharmaceuticals; custom manufacture of nano scale material for use in the manufacture of other goods; custom manufacturing of pharmaceutical preparations for use in gene therapy; custom manufacturing of pharmaceutical preparations for use in gene delivery technology; custom manufacturing of pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; custom manufacturing of pharmaceutical preparations for the treatment of disorders of the central nervous system; custom manufacturing of pharmaceutical preparations for the treatment of cancer; custom manufacture of pharmaceutical preparations that facilitate administration of other pharmaceutical preparations into the brain for enhanced treatment of disorders of the central nervous system and cancer.
Biomanufacturing, namely, custom manufacturing of pharmaceuticals using biological organisms in the manufacturing process; providing technical information in the field of pharmaceutical manufacturing; custom manufacture of pharmaceuticals; custom manufacture of nano scale material for use in the manufacture of other goods; custom manufacturing of pharmaceutical preparations for use in gene therapy; custom manufacturing of pharmaceutical preparations for use in gene delivery technology; custom manufacturing of pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; custom manufacturing of pharmaceutical preparations for the treatment of disorders of the central nervous system; custom manufacturing of pharmaceutical preparations for the treatment of cancer; custom manufacture of pharmaceutical preparations that facilitate administration of other pharmaceutical preparations into the brain for enhanced treatment of disorders of the central nervous system and cancer.
Class 42:
Pharmaceutical research and development in the field of gene therapy; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; custom development of biochemical reagents, namely, design and development for others of clinical medical reagents for use in gene therapy; development of pharmaceutical preparations for use in gene therapy and gene delivery technology; development of products being genetic therapies; scientific research in the field of genetic engineering, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools; research and development in the biotechnology field; scientific and medical research and development; scientific research and product development services for others in the pharmaceutical, biotechnology, medical and agriculture fields; testing, inspection, research, or development of pharmaceutical preparations for gene therapy and gene delivery technology; biomedical, scientific, pharmaceutical research and product development services in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; product development in the fields of genetic therapies, gene delivery technologies, and effectors to regulate, modulate, and characterize disease states; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; gene therapy design and delivery development of biochemical assays; biomedical, scientific, and pharmaceutical research and development services in the fields of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; genetic engineering services; scientific research in the field of gene therapy.
Pharmaceutical research and development in the field of gene therapy; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; custom development of biochemical reagents, namely, design and development for others of clinical medical reagents for use in gene therapy; development of pharmaceutical preparations for use in gene therapy and gene delivery technology; development of products being genetic therapies; scientific research in the field of genetic engineering, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools; research and development in the biotechnology field; scientific and medical research and development; scientific research and product development services for others in the pharmaceutical, biotechnology, medical and agriculture fields; testing, inspection, research, or development of pharmaceutical preparations for gene therapy and gene delivery technology; biomedical, scientific, pharmaceutical research and product development services in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; product development in the fields of genetic therapies, gene delivery technologies, and effectors to regulate, modulate, and characterize disease states; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; gene therapy design and delivery development of biochemical assays; biomedical, scientific, and pharmaceutical research and development services in the fields of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; genetic engineering services; scientific research in the field of gene therapy.
Class 44:
Medical services in the field of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; providing patient support services relating to the treatment of medical disorders, namely, providing online information in the field of pharmaceutical preparations for treatment of various diseases and providing medical consultancy and advisory services via a global computer network; providing health and medical information about medical disorders; information services, namely, providing medical information to patients; providing patient support services relating to cancer and cancer treatment in the nature of an internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; providing information services, namely, providing medical consultancy and advisory services via a global computer network in the field of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; providing information services relating to treatment of medical disorders, namely, providing information to patients and families of patients in the field of administering medication, and patient medical information where patients can inquire about medical issues and procedures from medical personnel.
Medical services in the field of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; providing patient support services relating to the treatment of medical disorders, namely, providing online information in the field of pharmaceutical preparations for treatment of various diseases and providing medical consultancy and advisory services via a global computer network; providing health and medical information about medical disorders; information services, namely, providing medical information to patients; providing patient support services relating to cancer and cancer treatment in the nature of an internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; providing information services, namely, providing medical consultancy and advisory services via a global computer network in the field of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; providing information services relating to treatment of medical disorders, namely, providing information to patients and families of patients in the field of administering medication, and patient medical information where patients can inquire about medical issues and procedures from medical personnel.